Billede af Sven Frøkjær

Sven Frøkjær

PhD (Pharm.)

19962019

Publikationer pr. år

Netværk

Willem Norde

  • Wageningen University & Research

Ekstern person

Jens Thostrup Bukrinsky

  • Novo Nordisk A/S (Biz)

Ekstern person

Susanne H Mollmann

  • University of Copenhagen

Ekstern person

Simon Bjerregaard

  • Novo Nordisk A/S (Biz)

Ekstern person

Jens Hansen

  • LEO-Pharma

Ekstern person

Kent Jorgensen

  • Technical University of Denmark
  • University of Copenhagen

Ekstern person

James M. Flink

  • Novo Nordisk A/S (Biz)

Ekstern person

Susanne Hostrup

  • Novo Nordisk A/S (Biz)

Ekstern person

Morten Colding-Jørgensen

  • Novo Nordisk A/S (Biz)
  • Novo Nordisk Foundation

Ekstern person

Jesper Donsmark

  • University of Copenhagen

Ekstern person

Katarina Jelic

  • Novo Nordisk Foundation

Ekstern person

Jens Thostrup Bukrinsky

  • Novozymes Biopharma A/S

Ekstern person

Dmitri I. Svergun

  • European Molecular Biology Laboratory, Hamburg

Ekstern person

Helle Bach Søndergaard

  • FARMA
  • University of Copenhagen

Ekstern person

Elisabeth Vestergaard

  • University of Southern Denmark

Ekstern person

Thorsten Thormann

  • LEO-Pharma

Ekstern person

Lone Dirckinck-Holmfeld

  • Aalborg Universitet

Ekstern person

Anne Plum

  • Novo Nordisk A/S (Biz)

Ekstern person

Peter Thygesen

  • Novo Nordisk A/S (Biz)

Ekstern person

Stig Jørgensen

  • Medicon Valley Alliance

Ekstern person

Shervin Bahrami

  • Aarhus Universitet

Ekstern person

Jens T. Bukrinsky

  • Novo Nordisk A/S (Biz)

Ekstern person

Nanna Aaby Kruse

  • Lægemiddelstyrelsen

Ekstern person

L. Lindgaard Hansen

  • Takeda Pharmaceutical Company Limited

Ekstern person

Bo Ahren

  • Lunds Universitet

Ekstern person

H. Yamamoto

  • Gifu Pharmaceutical University

Ekstern person

James M. Flink

  • Novo Nordisk A/S (Biz)

Ekstern person

J. Hansen

  • LEO-Pharma

Ekstern person

Simon Bjerregaard

  • Novo Nordisk A/S (Biz)

Ekstern person

Claus Vesterager Pedersen

  • Roskilde University

Ekstern person

Christian Rischel

  • Novo Nordisk Foundation

Ekstern person

Jørgen Staunstrup

  • IT Universitetet

Ekstern person

Kent Jørgensen

  • Technical University of Denmark

Ekstern person

B. Clausen-Beck

  • Royal Danish School of Pharmacy

Ekstern person

Jens T Bukrinsky

  • Novozymes Biopharma A/S

Ekstern person

H. Takeuchi

  • Gifu Pharmaceutical University

Ekstern person

Jesper Romhild Davidsen

  • Technical University of Denmark
  • University of Copenhagen

Ekstern person

Charlotte Vermehren

  • LiPlasome Pharma A/S

Ekstern person

Gerd Schluckebier

  • Novo Nordisk A/S (Biz)
  • Novo Nordisk Foundation

Ekstern person

Peter Kingshott

  • Forskningscenter Risø

Ekstern person

Ragnhild Djønne Salte

  • Department of Pharmacy, University of Copenhagen

Ekstern person

Charlotte Wiberg

  • Novo Nordisk A/S (Biz)

Ekstern person

Jan Høst

  • Ferrosan A/S

Ekstern person

Lise Wogensen Bach

  • Aarhus Universitet

Ekstern person

Y. Kawashima

  • Aichi Gakuin University
  • Gifu Pharmaceutical University

Ekstern person

Thomas Kaasgaard

  • Technical University of Denmark
  • University of Southern Denmark
  • CSIRO

Ekstern person

Raymond M. Schiffelers

  • University Medical Center Utrecht

Ekstern person

Ida Sofie Jensen

  • Lægemiddelindustriforeningen

Ekstern person

Manfred Roessle

  • European Molecular Biology Laboratory, Heidelberg

Ekstern person

Silvina A. Bravo

  • ETH Zurich

Ekstern person

Mathias Norrman

  • Novo Nordisk A/S (Biz)
  • Novo Nordisk Foundation

Ekstern person

S. Sønderkær

  • University of Copenhagen

Ekstern person

Inge Thøger Christensen

  • Novo Nordisk A/S (Biz)

Ekstern person

S. Velaga

  • Luleå University of Technology

Ekstern person

Mads C. Sabra

  • Technical University of Denmark

Ekstern person

Dmitri I. Svergun

  • European Molecular Biology Laboratory, Heidelberg

Ekstern person

Christian Rischel

  • Novo Nordisk A/S (Biz)

Ekstern person

Lotte Jensen

  • Copenhagen Business School

Ekstern person